The July 16th issue of Science Daily included an article about a research program at the University of Texas Medical School at Houston believe they have found a way to kill the virus that causes HIV.
Even though this was published two weeks ago, the news is just now appearing in the MSM. The news is an encouraging sign in the battle against HIV and AIDS.
The core part of the research focuses on antibodies that attack a non-changing part of the virus. Since the HIV virus is very changeable, regular antibody research has failed to produce a vaccine. This new approach holds out great promise.
"The work of Dr. Paul's group is highly innovative. They have identified antibodies that, instead of passively binding to the target molecule, are able to fragment it and destroy its function. Their recent work indicates that naturally occurring catalytic antibodies, particularly those of the IgA subtype, may be useful in the treatment and prevention of HIV infection," said Steven J. Norris, Ph.D., holder of the Robert Greer Professorship in the Biomedical Sciences and vice chair for research in the Department of Pathology and Laboratory Medicine at the UT Medical School at Houston.
A key bit of evidence that led to the discovery was the presence of effective antibodies that can be produced by Lupus patients and a small minority of AIDS victims that begin to produce antibodies years after they first become infected.
The abzymes are derived from HIV negative people with the autoimmune disease lupus and a small number of HIV positive people who do not require treatment and do not get AIDS. Stephanie Planque, lead author and UT Medical School at Houston graduate student, said, "We discovered that disturbed immunological events in lupus patients can generate abzymes to the Achilles heel of HIV.
Human studies have not yet begun, but early trials using human blood have proven positive.
Carl Hanson, Ph.D., who heads the Retrovirus Diagnostic Section of the Viral and Rickettsial Disease Laboratory of the California Department of Public Health, has shown that the abzymes neutralize infection of human blood cells by diverse strains of HIV from various parts of the world. Human blood cells are the only cells that HIV infects.
The research was funded by the National Institutes of Health and the Texas Higher Education Coordinating Board.
Dr. Paul, when asked in a television interview when a vaccine could be available, said the FDA predicted 15-20 years. He is more optimistic. He believes human trials can begin in as little as 6-9 months and that a vaccine could be available in 5-10 years.
Feel hope. It may be a four-letter word, but then so is love. Hope is a wonderful thing.
|
|
|
Permalink :: 27 Comments :: Post a Comment
|
In order to post a comment, you must be logged in. If you have a member account, please log in to comment.
If not, you can make an account right here. It's quick and free.